curacleltd Past Earnings Performance

Past criteria checks 0/6

curacleltd has been growing earnings at an average annual rate of 22.4%, while the Biotechs industry saw earnings growing at 14.4% annually. Revenues have been growing at an average rate of 40.5% per year.

Key information

22.4%

Earnings growth rate

46.6%

EPS growth rate

Biotechs Industry Growth11.7%
Revenue growth rate40.5%
Return on equity-36.6%
Net Margin-248.6%
Last Earnings Update31 Mar 2024

Recent past performance updates

No updates

Recent updates

curacleltd (KOSDAQ:365270) Has Debt But No Earnings; Should You Worry?

Jun 26
curacleltd (KOSDAQ:365270) Has Debt But No Earnings; Should You Worry?

Is Curacle (KOSDAQ:365270) Using Too Much Debt?

Feb 27
Is Curacle (KOSDAQ:365270) Using Too Much Debt?

Revenue & Expenses Breakdown

How curacleltd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A365270 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 245,799-14,41818,6640
31 Dec 2310,294-11,58619,8410
30 Sep 2310,061-10,59818,787873
30 Jun 238,668-8,48216,201558
31 Mar 237,928-9,51116,731-234
31 Dec 223,583-11,40614,6580
30 Sep 228,799-4,62117,781-4,075
30 Jun 227,926-6,97714,498447
31 Mar 226,905-6,21912,468740
31 Dec 216,255-6,67812,080607
30 Sep 210-18,9049,858374
31 Mar 210-27,8908,559-940
31 Dec 200-28,6107,031479
31 Dec 190-13,9891,4254,218

Quality Earnings: A365270 is currently unprofitable.

Growing Profit Margin: A365270 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A365270 is unprofitable, but has reduced losses over the past 5 years at a rate of 22.4% per year.

Accelerating Growth: Unable to compare A365270's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A365270 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (13.4%).


Return on Equity

High ROE: A365270 has a negative Return on Equity (-36.63%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.